
CVS · NYSE
CVS Health operates across health insurance, pharmacy services and retail pharmacy and consumer-health businesses. Its Health Care Benefits business serves members through Aetna insurance products; Health Services provides pharmacy-benefit management and related services to employers, insurers, government programs and other organizations; and Pharmacy and Consumer Wellness operates pharmacies and health-focused retail locations serving consumers. The supplied evidence does not provide revenue contributions by segment. CVS generated $402.1 billion of revenue and $1.8 billion of net income in FY2025, compared with $372.8 billion and $4.6 billion, respectively, in FY2024.
CVS fell $4.92, or 4.50%, from $109.34 to $104.42 over the supplied week. The main move was a $3.42 drop on July 29, followed by smaller declines on July 30 and July 31, which left the stock down 4.49% before the final two sessions. CVS recovered $0.94, or 0.90%, on August 3, then gave back that gain and another $0.01 on August 4. The supplied evidence does not identify a company-specific announcement driving the decline. Instead, trading occurred ahead of CVS’s scheduled August 5 earnings release, while an ETF report cited large outflows from the iShares Russell Top 200 Value ETF, providing broader positioning context rather than a direct CVS catalyst.